CA2489988A1 - Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives - Google Patents

Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives Download PDF

Info

Publication number
CA2489988A1
CA2489988A1 CA002489988A CA2489988A CA2489988A1 CA 2489988 A1 CA2489988 A1 CA 2489988A1 CA 002489988 A CA002489988 A CA 002489988A CA 2489988 A CA2489988 A CA 2489988A CA 2489988 A1 CA2489988 A1 CA 2489988A1
Authority
CA
Canada
Prior art keywords
alkyl
optionally substituted
heteroaryl
groups
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002489988A
Other languages
English (en)
French (fr)
Inventor
Michael R. Reeder
Rick J. Imbordino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2489988A1 publication Critical patent/CA2489988A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
CA002489988A 2002-06-20 2003-06-20 Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives Abandoned CA2489988A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39028502P 2002-06-20 2002-06-20
US60/390,285 2002-06-20
US45047803P 2003-02-27 2003-02-27
US60/450,478 2003-02-27
PCT/US2003/019585 WO2004000821A1 (en) 2002-06-20 2003-06-20 Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives

Publications (1)

Publication Number Publication Date
CA2489988A1 true CA2489988A1 (en) 2003-12-31

Family

ID=30003150

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002489988A Abandoned CA2489988A1 (en) 2002-06-20 2003-06-20 Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives

Country Status (17)

Country Link
US (2) US7115747B2 (cg-RX-API-DMAC7.html)
EP (1) EP1532123B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005533811A (cg-RX-API-DMAC7.html)
CN (1) CN1324017C (cg-RX-API-DMAC7.html)
AT (1) ATE370131T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003249344A1 (cg-RX-API-DMAC7.html)
BR (1) BR0312439A (cg-RX-API-DMAC7.html)
CA (1) CA2489988A1 (cg-RX-API-DMAC7.html)
CO (1) CO5670350A2 (cg-RX-API-DMAC7.html)
DE (1) DE60315664D1 (cg-RX-API-DMAC7.html)
EA (1) EA008389B1 (cg-RX-API-DMAC7.html)
IL (1) IL165763A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA04012630A (cg-RX-API-DMAC7.html)
NO (1) NO20045497L (cg-RX-API-DMAC7.html)
NZ (1) NZ537390A (cg-RX-API-DMAC7.html)
PL (1) PL374999A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004000821A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040762A1 (es) * 2002-11-27 2004-11-06 Elan Pharm Inc Ureas substituidas y carbamatos utiles para el tratamiento de la enfermedad de alzheimer
TW200738701A (en) * 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
EP1971598A1 (en) 2005-11-21 2008-09-24 Amgen Inc. Beta-secretase modulators and methods of use
US7745484B2 (en) * 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
US7872009B2 (en) 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
US7838676B2 (en) * 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
US20080277393A1 (en) * 2007-05-07 2008-11-13 True Charles W Collapsible, stackable, semi-rigid universal cotainer for hazardous and non-hazardous goods
CL2008001500A1 (es) 2007-05-25 2008-12-26 Amgen Inc Compuestos derivados de hidroxietil amina sustituidas, moduladores de betasecretasa; proceso de preparacion de dichos c ompuestos; composicion farmaceutica que los comprende; y su uso para tratar un trastorno neurologico, tal como alzheimer, sindrome de down, demencia degenerativa, entre otros.
CA2687608C (en) 2007-05-25 2013-07-02 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
US7803809B2 (en) 2008-11-12 2010-09-28 Amgen Inc. Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
MX2011002705A (es) 2008-09-11 2011-09-09 Amgen Inc Compuestos con anillos espiro-triciclicos como moduladores de beta-secretasas y metodos de uso.
US8822485B2 (en) 2009-11-23 2014-09-02 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
WO2011063233A1 (en) 2009-11-23 2011-05-26 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
WO2011090911A1 (en) 2010-01-19 2011-07-28 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
MX2012010658A (es) 2010-03-15 2012-12-05 Amgen Inc Compuestos de anillo espiro tetraciclico como moduladores de beta-secretasa.
US8497264B2 (en) 2010-03-15 2013-07-30 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9346827B2 (en) 2011-02-07 2016-05-24 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9725469B2 (en) 2012-11-15 2017-08-08 Amgen, Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9462841B1 (en) 2016-03-01 2016-10-11 William Popejoy Protective headgear and shoulder pad apparatus and methods
US11272751B2 (en) 2016-03-01 2022-03-15 Nicholas Popejoy Protective headgear, impact diffusing systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020276A1 (es) * 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
CA2462851A1 (en) * 2001-10-04 2003-04-10 Elan Pharmaceuticals, Inc. Hydroxypropylamines
AR039555A1 (es) * 2001-11-08 2005-02-23 Upjohn Co Derivados n,n'-sustituidos de 1,3-diamino-2-hidroxipropano
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
US7115747B2 (en) 2006-10-03
BR0312439A (pt) 2005-05-10
ATE370131T1 (de) 2007-09-15
EA008389B1 (ru) 2007-04-27
DE60315664D1 (de) 2007-09-27
CN1662510A (zh) 2005-08-31
US20040063965A1 (en) 2004-04-01
MXPA04012630A (es) 2005-09-30
PL374999A1 (en) 2005-11-14
EA200401510A1 (ru) 2005-06-30
US20070105921A1 (en) 2007-05-10
WO2004000821A1 (en) 2003-12-31
EP1532123A1 (en) 2005-05-25
NZ537390A (en) 2006-07-28
CN1324017C (zh) 2007-07-04
CO5670350A2 (es) 2006-08-31
JP2005533811A (ja) 2005-11-10
NO20045497D0 (no) 2004-12-16
IL165763A0 (en) 2006-01-15
EP1532123B1 (en) 2007-08-15
NO20045497L (no) 2005-03-07
AU2003249344A1 (en) 2004-01-06
HK1081543A1 (zh) 2006-05-19

Similar Documents

Publication Publication Date Title
US7115747B2 (en) Process for preparing oxazole intermediates
EP2062874B1 (en) Process and intermediates for the preparation of aliskiren
JP6531235B1 (ja) 新規アルキルジフェニルメタン保護剤
KR102421025B1 (ko) 신규 트리틸 보호제
RU2742005C2 (ru) Способы получения 4-алкокси-3-(ацил или алкил)оксипиколинамидов
JP6393857B1 (ja) 新規四環式保護剤
CA2660736A1 (en) Process and intermediates for the synthesis of 2-(quinolin-5-yl)-4,5 disubstituted-azole derivatives
KR910007887B1 (ko) 1,4-디아자비사이클로[3.2.2]노난의 제조방법
CN113636964B (zh) 一种芳基二硒醚类有机硒化合物的绿色制备方法
CA2357953A1 (en) Process for preparing n-[1-(s)-ethoxycarbonyl-3-phenylpropyl]-l-alanine n-carboxyanhydride
CN109574860B (zh) 一种制备维兰特罗的方法
KR20050019766A (ko) 5-(1,3-옥사졸-2-일)벤조산 유도체의 제조 방법
JP2022035954A (ja) N-Boc-ラクタム誘導体及びその製造方法、並びに、環状アミン誘導体の製造方法
CN119241385B (zh) β-酰氧基烯酰胺衍生物及其制备方法和应用
CN119735513B (zh) 一种非保护1,2-氨基酯及噁唑啉衍生物的合成方法
CN116693428B (zh) 一种三(对甲苯磺酰氧甲基)硝基甲烷的合成方法
Wang et al. Synthesis and biological activity of novel N‐tert‐butyl‐N, N′‐substitutedbenzoylhydrazines containing 2‐methyl‐3‐(triphenylgermanyl) propoxycarbonyl
CN120329233A (zh) 乌帕替尼中间体的制备方法及其中间体
JP3074665B2 (ja) 新規ヒドラゾン化合物、及びトリアゾール化合物の製造法
CN122036557A (zh) 一种环丝氨酸中间体及用途
JPH0525876B2 (cg-RX-API-DMAC7.html)
JPH0350740B2 (cg-RX-API-DMAC7.html)
JPH0577670B2 (cg-RX-API-DMAC7.html)
JP2001151745A (ja) 3−ニトロ−2−(N−t−ブトキシカルボニル)アミノ安息香酸エステル類の製造法およびその製造中間体
JPS59163325A (ja) カルボン酸エステルの製造法

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20090622